Continuing Education Credits

The Compliance Certification Board (CCB)® has approved this event for up to 9.4 Live CCB CEUs, based on a 50-minute hour, each.. Continuing Education Units are awarded based on individual attendance records. Granting of prior approval in no way constitutes endorsement by CCB of this event content or of the event sponsor.

RISE is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: www.nasbaregistry.org  

PROGRAM KNOWLEDGE LEVEL: Basic
ANTICIPATED CPE CREDITS:  Main Conference + Workshops: 10.7 CPEs
RECOMMENDED FIELD(S) OF STUDY: Specialized Knowledge
PREREQUISITES: NONE 
ADVANCE PREPARATION: NONE
INSTRUCTIONAL DELIVERY METHOD: GROUP LIVE 
ATTENDANCE REQUIREMENTS:
To be awarded the full credit hours, you must be present, registering your attendance and departure in the attendance survey (Survey Monkey)
 
LEARNING OBJECTIVES: UPON COMPLETING THE COURSE, PARTICIPANTS WILL:

• Understand how IRA-driven changes to Part D benefits impact actuarial forecasting, plan design, and member experience
• Balance member access, cost containment, and compliance amid ongoing policy shifts and market pressures
• Explore key takeaways from the CMS Final Rule and Call Letter, and what they mean for plan compliance and operations in 2025 and beyond
• Operationalize compliance improvements using real-time tracking tools, internal dashboards, and effective system strategies
• Strengthen clinical and financial forecasting to accurately account for high-cost therapies, pipeline products, and shifting plan liabilities\
• Hear directly from beneficiaries about what’s working (and what’s not) in their Medicare Part D experiences—from choosing plans to medication affordability
• Manage rising costs of GLP-1s and gene therapies while maintaining clinical excellence and financial sustainability
• Identify Part D measures that most influence Star Ratings, including adherence, MTM, and CMR completion\
• Benchmark best practices and network with industry peers to remain competitive in a rapidly transforming market
• Discover real-world examples of how successful plans tackled formulary changes, OOP cap implementation, and audit readiness

For more information regarding complaints, concerns, or cancellation policies, please visit our website, https://risehealth.org/the-fine-print/ or contact us at confirm@risehealth.org.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and RISE Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Professions in scope for this activity are listed below.

Amedco Joint Accreditation Provider Number: 4008163

Pharmacists & Pharmacy Technicians

Amedco LLC designates this activity for a maximum of 8.50 knowledge-based CPE contact hours.

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.